Navigation Links
Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting
Date:8/19/2009

NOVATO, Calif., Aug. 19 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that data from clinical studies of Kuvan(R) (sapropterin dihydrochloride) and Naglazyme(R) (galsulfase) will be presented at the 11th Annual Meeting of the International Congress of Inborn Errors of Metabolism (ICIEM) in San Diego, California, August 29 through September 2, 2009.

"We look forward to a number of abstracts, posters and platform presentations that will highlight a variety of topics on the treatment of PKU and MPS VI. In particular, results from the PKU studies will hopefully strengthen the safety and efficacy data for Kuvan and demonstrate both the broad use of the medicine across different patient populations as well as possible neurocognitive benefits," said Chief Medical Officer Hank Fuchs, M.D.

The following abstracts, posters and presentations will be featured:

Phenylketonuria (PKU)

#171: Sapropterin Dihydrochloride Response in 35 Patients with Hyperphenylalaninemia (Vernon, et al)

#179: Clinical Experience with KUVAN Therapy in Young Children with Phenylketonuria (PKU) (Mofidi, et al)

#185: An Outreach Program for Adults Living with PKU (Leviton and Burton)

#187: PKU Treatment with Tetrahydrobiopterin (Sapropterin) During Pregnancy (Cunningham, et al)

#192: Treatment of an Individual with Phenylketonuria and Neurological Impairment with Sapropterin (Adams)

#195: The KUVAN Adult Maternal Pediatric European Registry (KAMPER): A Long Term Observational Study of Patients with Hyperphenylalaninaemia Treated with KUVAN (Champigneulle, et al)

#202: Responsiveness of KUVAN in PKU Patients Du
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan
2. BioMarin Receives 2009 Corporate Award for the Development of Kuvan
3. Fairview Specialty Pharmacy Signs Contract With BioMarin for Distribution of Kuvan(TM)
4. BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono
5. Centers of Excellence Awards Presented to Over 100 Nursing Facilities as Nursing Facilities Reach the Tipping Point in Treating Pressure Ulcers
6. CRF announces late breaking trials to be presented at TCT 2009 in San Francisco
7. Webinar on "Physician Engagement - Diagnosing Generational Differences" Presented by Morehead Associates
8. Webinar on "Physician Engagement - Diagnosing Generational Differences" Presented by Morehead Associates
9. President Obama Presented With Startling Book The Art of Conscious Parenting by the American Foundation for Conscious Parenting
10. 96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy
11. Shoulder Surgery Doesn't Prevent Return to Sports, According to New Study presented at AOSSM Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Developed by Opticom Data Research, FloatScope i...on of the eye. , New West...e is a new hand-held device for self-examination o...lar health conditions such as floaters and opaciti...ioning of the iris., , , FloatScope uses a beam o...
(Date:11/23/2009),, NEWYORK,Nov.23/PRNewswire/--Livingwithchronicpaincanbedifficult-andthestressoftheholidayseasoncanprovetobequitechallengingforthoselivingwithpain. ,, ListentothisreportfromPfizerInc.at: ,
(Date:11/23/2009)...ofMedicalGenetics(ACMG)EncouragesFamiliestoGatherF...ryDay,Thanksgiving2009 ,, BETHESDA,Md.,Nov.23/...annualNationalFamilyHistoryDay,asdeclaredbytheU.S....(ACMG)encourageseveryonetoknowtheirfamilymedicalhi...ylife-savinginformation,to"starttheconversation"ab...
(Date:11/23/2009)...3/PRNewswire-USNewswire/--TheAmericanSocietyofHema...hing,education,andmediacompany,arelaunching"Explor...nedtosparkinterestinthefieldsofscienceandmedicine,...unitiesinhematology. ,, "Manyhematologistsmayre...nificent,whichmadelearningaboutbloodreallyfun,"sta...
(Date:11/23/2009)...9) -- A first-of-its-kind consensus statement on d...Annals of Surgery . The report illustrates the fin...nce -- Diabetes Surgery Summit (DSS) -- where an i...medical experts agreed on a set of evidence-based ... the use and study of gastrointestinal surgery to ...
Breaking Medicine News(10 mins):Health News:FloatScope - A New Device for Self-Viewing Eye Floaters 2Health News:'Family Health History and Genetics Privacy' is the Newest Addition to the ACMG Genetics & Your Health Video Series 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5
... dormant cells switch ,on, in those with lupus, rh...althDay News) -- Healthy adults have potential aut...y in an "off" state, a U.S. study shows. , Immune ... true precursors of the self-attacking immune cell...
...atchet up mental health problems already more comm...(HealthDay News) --Sagging spirits, sagging econom...ple both blue and broke -- the usual melancholy ...ing the winter months not only because of the holi...
... Parker College of Chiropractic offers ... economic times. The chiropractic school provides ...ical professions. , (PRWE...ents. During today,s economic downturn, when many ...
... 2008, Cambridge, UK Scientists report that human...ct the severity of Batten Disease, a fatal nervous... new study published in Disease Models & Mechanis...al, milder symptoms of Batten disease appear in ch...
...with particular variants of certain genes involved...in cigarette smoke have an increased risk of devel... study published in the February 1, 2009 issue of ...mportant implications for preventing smoking-relat...
...tips can take the guilt, and the calories, out of ...y News) -- Rather than worry about gaining or losi...ping steady on the scales by following some simple...fer Ventrelle, clinical nutritionist and registere...
Other Medicine News:Health News:Blue and Broke for the Holidays 2Health News:Blue and Broke for the Holidays 3Health News:Blue and Broke for the Holidays 4Health News:Parker College of Chiropractic Education Launches Recruiting Campaign for Career Changers and Potential Students 2Health News:SNPs of ABC transporter genes linked to lung cancer risk 2Health News:Eating Strategies for Healthier Holiday Parties 2
(Date:11/23/2009)...valsoftwonewtherapiesforNon-Hodgkin,sLymphomas(NHL...fatumumab(Azerra(TM),GlaxoSmithKline)asatherapyopt...ndromidepsin(Istodax(R),GloucesterPharmaceuticals)...llymphoma(CTCL). ,, FORTWASHINGTON,Pa.,Nov.23/P...omptedtheNationalComprehensiveCancerNetwork( NCCN ...
(Date:11/23/2009)...swire/--Reportlinker.comannouncesthatanewmarketres...hesiaDisposables-AWorldMarketReview ,, http:...bles---A-World-Market-Review.html#utm_source=prnew...e ,, Globalgeneralanesthesiadisposablesmark...theconsiderablerisewitnessedingeneralsurgicalproce...
(Date:11/23/2009)...ov.23/PRNewswire-FirstCall/-- LexiconPharmaceutica...datafromitsPhase2clinicalstudywith LX1031 inpatien...illbepresentedatGASTRO2009inLondonthisweek.Results...BSsymptoms,willbepresentedbyDr. PhilipM.Brown ,Lex...ovember25,2009at2:30pmlocaltimeatthesessionentitle...
Breaking Medicine Technology:NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3MSU scientists 3A Progesterone leads to inflammation 54891 1MSU scientists 3A Progesterone leads to inflammation 54891 2Vanderbilt joins national consortium to develop new cancer therapies 54888 1Vanderbilt joins national consortium to develop new cancer therapies 54888 2Vanderbilt joins national consortium to develop new cancer therapies 54888 3American Society for Microbiology honors Tobias M Hohl for work on Aspergillus fumigatus 9622 1American Society for Microbiology honors Tobias M Hohl for work on Aspergillus fumigatus 9622 2American Society for Microbiology honors Tobias M Hohl for work on Aspergillus fumigatus 9622 3
...il 30 Arrayit Corporation (OTC Bulletin Board: AR...es for disease prevention, treatment and cure, ann...sed diagnostic test to detect the H1N1 swine flu v...s and clinicians to detect the presence of the vir...nguish the threatening mutated strain from less ha...
...in the second half of this year , , BERLIN and TA...egeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) t...eir global development program for VEGF Trap-Eye, ...ain eye diseases, to include Central Retinal Vein ... Phase 3 program evaluating the efficacy and safet...
Other Medicine Technology:Arrayit to Mass Produce Rapid H1N1 Swine Flu Test Chip 2Arrayit to Mass Produce Rapid H1N1 Swine Flu Test Chip 3Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion 2Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion 3Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion 4Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion 5
Brooks Brothers Ophthalmic Collection
Chanel Optical Collection
...lly fresh restatement of everything thats creative...gamo.,The creations include eighteen ladies models...odels.,The style icons of the Florentine brand rea... designs, striking details and prestige materials....
...he Anne Klein brand under license since 1996. The ... all-female market. The woman who chooses to wear ...ical modern woman: a successful and refined career...s and loves a sleek yet at the same time practical...
Medicine Products: